Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF OTHER ACCRUED EXPENSES (Details)

v3.21.2
SCHEDULE OF OTHER ACCRUED EXPENSES (Details) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Accrued royalties $ 3,320 $ 2,710
Upfront Medicare payment 1,174 2,066
Operating lease liability 898 1,027
All others 897 1,182
Accrued professional fees 719 854
Unclaimed property 565 565
Contingent consideration 459 398
Accrued capital expenditures 295
Accrued pharma services invoices 293 108
Taxes payable 289 334
Accrued lab costs - diagnostics 172 161
Financing lease liability 117 177
ESPP payable 88 108
Accrued sales and marketing - diagnostics 78 51
Deferred revenue 43 54
Total other accrued expenses $ 9,407 $ 9,795